Fuelling Innovation in a Crucial Space
The successful funding round represents a tremendous achievement for Hello Inside's team of founders and investors, especially given the current economic challenges, particularly in the FemTech sector. This funding is not just a testament to the company's potential, but also a critical step toward driving innovation, research, and product development in a sector that has historically been underfunded and under-researched. Despite being a $44 billion market globally, only 4% of health tech funding in 2023 was directed towards FemTech. This investment is crucial in ensuring that this space receives the attention and resources it deserves
Scarlett Chen, the lead investor from Verge Fund, emphasized the importance of this investment: "We see enormous potential in Hello Inside, not only in terms of market opportunity but also in the positive impact it can have on women's health worldwide. The highly disciplined and performance-driven team has created one of the most engaging digital health apps globally. The unique combination of cutting-edge technology and the focus on women's specific health needs aligns perfectly with our mission at Verge HealthTech Fund."
Transformative Technology for Women's Health
Hello Inside's platform integrates third-party continuous glucose monitoring (CGM) with advanced AI technology to provide women with a comprehensive understanding of their metabolic health. By tracking and logging lifestyle & health data (Food, Movement, Stress and Sleep), the platform empowers users to make informed decisions about their health and wellness. The system already works seamlessly with other leading health services, such as the Oura Ring or Apple Health, to offer a holistic approach to health tracking and behavior change. The human metabolism is fundamentally complex, individual and subject to change. Analyzing and interpreting all metabolic health data with the help of AI unlocks a huge potential for consumers and enables a new understanding of their own bodies.
Building on its initial success and the fantastic user response-averaging 10+ app opens per user per day and achieving an 80% weight-goal success rate within 30 days-Hello Inside plans to use this funding to further clinically validate its engagement model and roll out a B2B offering. These developments will position the company as a key player in the evolving FemTech landscape.
Mario Aichlseder, CEO of Hello Inside, highlights the unique value of the platform: "Attention is the key to behavior change and positive health impact. By pairing this with the power of AI and the knowledge of our medical experts, we can offer women a profound understanding of their metabolic health. Our technology is not just about tracking data, but about providing actionable insights that lead to meaningful changes in health and wellness."
Hello Inside is poised to build on the recent successes of trailblazers like Oura and Clue as it continues its mission to support women on their metabolic health journeys. Despite the challenges faced in securing funding, the company's recent achievements, coupled with the rise of the first EU health unicorn, Flo, have turned the spotlight onto FemTech. With all eyes on this sector, Hello Inside anticipates that 2025 will bring even greater opportunities for growth and impact.
About
Hello Inside is a CGM-enabled metabolic health service dedicated to empowering women through better metabolic health. With a focus on innovation and user-centric design, the service provides AI-powered tools and insights that allow women to take control of their health in previously unimaginable ways. By bridging the gap between technology and health, Hello Inside is leading the way in a new era of FemTech. https://helloinside.com/
Contact
Roots Health GmbH
Kopernikusgasse 8/20
1060 Vienna, Austria
Email: office@helloinside.com